GlassScriptPhysician profile
Robert W Rigg
NPI 1497783187
$7,730.92
in general payments reported to CMS, 2019-2025
18 companies · $1,867 in 2025
The $1,867 reported for 2025 was more than what 96% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $149 · 2021: $2,084 · 2022: $604 · 2023: $1,333 · 2024: $1,207 · 2025: $1,867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,406.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,929.88 | 2021-2025 | Ubrelvy, Qulipta |
| Amgen INC. | $1,456.57 | 2023-2025 | Repatha, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $1,266.08 | 2019-2025 | Airsupra, Breztri |
| Paratek Pharmaceuticals, INC. | $812.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $349.93 | 2021 | |
| Abbott Laboratories | $347.82 | 2023-2025 | Proclaim, Freestyle Libre 3, Eterna |
| Pfizer INC. | $293.04 | 2023-2025 | |
| Spr Therapeutics, INC | $252.05 | 2023-2024 | Sprint Pns System |
| Novo Nordisk INC | $250.00 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $201.75 | 2022 | |
| Inspire Medical Systems, INC. | $163.16 | 2025 | Inspire |
| Boston Scientific Corporation | $115.29 | 2025 | Intracept |
| Redhill Biopharma INC. | $114.21 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $74.32 | 2019-2023 | Livalo, Seglentis |
| Amarin Pharma, INC. | $55.83 | 2020-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $19.89 | 2021 | |
| Therapeuticsmd, INC. | $15.02 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rigg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.